IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
Pharmaceutical Preparations Manufacturing in Germany Industry Data and Analysis
The heavy reliance on Chinese active ingredients and intermediates is a major challenge for the domestic manufacture of pharmaceutical products. It increases the vulnerability of supply chains and shifts the balance of bargaining power in favour of Asian suppliers. At the same time, the importance of biopharmaceuticals is growing; sales of these products are rising significantly thanks to high medical demand and targeted therapies, from which research-intensive companies such as BioNTech are benefiting. To remain competitive against suppliers from China and India, manufacturers are investing more heavily in digitalisation, automation and the use of AI, which boosts efficiency and enables continuous manufacturing processes. At the same time, the Statutory Health Insurance Financial Stabilisation Act is weighing on profitability due to higher manufacturer discounts and the extended price moratorium, prompting many companies to turn increasingly to export markets. This is counterbalanced by the measures set out in the Federal Government’s pharmaceutical strategy and the Medical Research Act, which are designed to create better framework conditions for research, clinical trials and production, and to make Germany an attractive location for the pharmaceutical industry once again. Over the past five years, turnover in the pharmaceutical industry has fallen by an average of 1.5% per year, and by 2026, industry turnover is expected to stand at 115.6 billion euros. This represents growth of 2.2% compared with the previous year.
Ways to access
Get this data your way
Explore the flexible connection options to access data and analysis.
What's included in this industry analysis
IBISWorld's research coverage on the Pharmaceutical Preparations Manufacturing industry in Germany includes market sizing, forecasting, data and analysis from 2016-2031. The most recent publication was released July 2026.
About this industry
What's this industry report about?
The Pharmaceutical Preparations Manufacturing industry in Germany operates under the WZ industry code C21.20DE. This sector encompasses the manufacture of specialised pharmaceuticals and other pharmaceutical products. These include pharmaceutical preparations such as antisera, blood components, vaccines and various medicines, as well as chemical and hormonal contraceptives. Furthermore, the sector includes the manufacture of diagnostic preparations, including pregnancy tests, as well as radioactive substances for in vivo diagnostics and biotechnological pharmaceutical products. Furthermore, the sector covers the manufacture of medical cotton wool, gauze, bandages and other dressing materials, as well as the processing of botanical products for pharmaceutical purposes. It does not include wholesale and retail trade, research and development, or the mere packaging of pharmaceutical products. Related terms covered in the Pharmaceutical Preparations Manufacturing industry in Germany include biopharmaceuticals/biologics , biosimilars , over-the-counter medicines , bioinformatics, generic medicines and homeopathy .
What's included in this industry?
Products and services covered in Pharmaceutical Preparations Manufacturing industry in Germany include Original prescription-only medicines, Prescription-only generic medicines and Over-the-counter medicines.
What companies are included in this industry?
Companies covered in the Pharmaceutical Preparations Manufacturing industry in Germany include F. Hoffmann-La Roche AG, Boehringer Ingelheim Pharma GmbH & Co. KG and Bayer AG.
Performance
What's included in the Performance chapter?
The Performance chapter covers detailed analysis, datasets, detailed current performance, sources of volatility and an outlook with forecasts for the Pharmaceutical Preparations Manufacturing industry in Germany.
Questions answered in this chapter include what's driving current industry performance, what influences industry volatility, how do successful businesses overcome volatility, what's driving the industry outlook. This analysis is supported with data and statistics on industry revenues, costs, profits, businesses and employees.
Products & Markets
What's included in the Products and Markets chapter?
The Products and Markets chapter covers detailed product and service segmentation, analysis of major markets and international trade data for the for the Pharmaceutical Preparations Manufacturing industry in Germany.
Questions answered in this chapter include how are the industry's products and services performing, what are innovations in industry products and services, what products or services do successful businesses offer and what's influencing demand from the industry's markets. This includes data and statistics on industry revenues by product and service segmentation and major markets.
Geographic Breakdown
What's included in the Geographic Breakdown chapter?
The Geographic Breakdown chapter covers detailed analysis and datasets on regional performance of the Pharmaceutical Preparations Manufacturing industry in Germany.
Questions answered in this chapter include where are industry businesses located and how do businesses use location to their advantage. This includes data and statistics on industry revenues by location.
Competitive Forces
What's included in the Competitive Forces chapter?
The Competitive Forces chapter covers the concentration, barriers to entry and supplier and buyer profiles in the Pharmaceutical Preparations Manufacturing industry in Germany. This includes data and statistics on industry market share concentration, barriers to entry, substitute products and buyer & supplier power.
Questions answered in this chapter include what impacts the industry's market share concentration, how do successful businesses handle concentration, what challenges do potential industry entrants face, how can potential entrants overcome barriers to entry, what are substitutes for industry services, how do successful businesses compete with substitutes and what power do buyers and suppliers have over the industry and how do successful businesses manage buyer & supplier power.
Companies
What's included in the Companies chapter?
The Companies chapter covers Key Takeaways, Market Share and Companies in the Pharmaceutical Preparations Manufacturing industry in Germany. This includes data and analysis on companies operating in the industry that hold a market share greater than 5%.
Questions answered in this chapter include what companies have a meaningful market share and how each company is performing.
External Environment
What's included in the External Environment chapter?
The External Environment chapter covers Key Takeaways, External Drivers, Regulation & Policy and Assistance in the Pharmaceutical Preparations Manufacturing industry in Germany. This includes data and statistics on factors impacting industry revenue such as economic indicators, regulation, policy and assistance programs.
Questions answered in this chapter include what demographic and macroeconomic factors impact the industry, what regulations impact the industry, what assistance is available to this industry.
Financial Benchmarks
What's included in the Financial Benchmarks chapter?
The Financial Benchmarks chapter covers Key Takeaways, Cost Structure, Financial Ratios, Valuation Multiples and Key Ratios in the Pharmaceutical Preparations Manufacturing industry in Germany. This includes financial data and statistics on industry performance including key cost inputs, profitability, key financial ratios and enterprise value multiples.
Questions answered in this chapter include what trends impact industry costs and how financial ratios have changed overtime.
Industry Data
What's included in the Industry Data chapter?
The Industry Data chapter includes 10 years of historical data with 5 years of forecast data covering statistics like revenue, industry value add, establishments, enterprises, employment and wages in the Pharmaceutical Preparations Manufacturing industry in Germany.
Access this data your way
The Pharmaceutical Preparations Manufacturing in Germany Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is the market size of the Pharmaceutical Preparations Manufacturing industry in Germany in 2026?
The market size of the Pharmaceutical Preparations Manufacturing industry in Germany is €115.6bn in 2026.
How many businesses are there in the Pharmaceutical Preparations Manufacturing industry in Germany in 2026?
There are 585 businesses in the Pharmaceutical Preparations Manufacturing industry in Germany, which has grown at a CAGR of 0.3 % between 2021 and 2026.
How may import tariffs affect the Pharmaceutical Preparations Manufacturing industry in Germany?
The Pharmaceutical Preparations Manufacturing industry in Germany is likely to be significantly impacted by import tariffs with imports accounting for a high share of industry revenue.
How may export tariffs affect the Pharmaceutical Preparations Manufacturing industry in Germany?
The Pharmaceutical Preparations Manufacturing industry in Germany is likely to be significantly impacted by export tariffs with exports accounting for a high share of industry revenue.
Has the Pharmaceutical Preparations Manufacturing industry in Germany grown or declined over the past 5 years?
The market size of the Pharmaceutical Preparations Manufacturing industry in Germany has been growing at a CAGR of 1.5 % between 2021 and 2026.
What is the forecast growth of the Pharmaceutical Preparations Manufacturing industry in Germany over the next 5 years?
Over the next five years, the Pharmaceutical Preparations Manufacturing industry in Germany is expected to grow.
What are the biggest companies in the Pharmaceutical Preparations Manufacturing industry in Germany?
The biggest companies operating in the Pharmaceutical Preparations Manufacturing industry in Germany are F. Hoffmann-La Roche AG, Boehringer Ingelheim Pharma GmbH & Co. KG and Bayer AG
What does the Pharmaceutical Preparations Manufacturing industry in Germany include?
Original prescription-only medicines and Prescription-only generic medicines are part of the Pharmaceutical Preparations Manufacturing industry in Germany.
Which companies have the highest market share in the Pharmaceutical Preparations Manufacturing industry in Germany?
The company holding the most market share in the Pharmaceutical Preparations Manufacturing industry in Germany is F. Hoffmann-La Roche AG.
Cut through the noise with intelligence you can trust
